The use of naltrexone in the management of severe generalized pruritus in biliary atresia: Report of a case

Pediatric Dermatology

Volumn 25, Issue 3, 2008, Pages 403-404

  Chang, Yuchi ^a   Golkar, Linda ^a,b  

^a LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

^b Faculty Medical Offices   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; COLESTYRAMINE; NALTREXONE; RIFAMPICIN; STEROID; URSODEOXYCHOLIC ACID;

ADD ON THERAPY; ARTICLE; BEDTIME DOSAGE; BILE DUCT ATRESIA; CASE REPORT; DISEASE SEVERITY; DRUG DOSE INCREASE; DRUG WITHDRAWAL; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MORNING DOSAGE; PHYSICAL EXAMINATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SKIN PRURITUS; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ANTIPRURITICS; BILIARY ATRESIA; CHOLESTASIS; HUMANS; INFANT; MALE; NALTREXONE; NARCOTIC ANTAGONISTS; PRURITUS; XANTHOMATOSIS;

EID: 44949258989     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2008.00699.x     Document Type: Article

References (5)

1. Mela M, Mancuso A, Burroughs AK. Review article: pruritus in cholestatic and other liver diseases. Aliment Pharmacol Ther 2003 17 : 857 870.
2. Cynamon HA, Andres JM, Iafrate RP. Rifampin relieves pruritus in children with cholestatic liver disease. Gastroenterology 1990 98 : 1013 1016.
3. Maxwell LG, Kaufmann SC, Bitzer S et al. The effects of a small-dose naloxone infusion on opioid-induced side effects and analgesia in children and adolescents treated with intravenous patient-controlled analgesia: a double-blind, prospective, randomized, controlled study. Anesth Analg 2005 100 : 953 958.
4. Bergasa NV, Schmitt JM, Talbot TL et al. Open-label trial of oral nalmefene therapy for the pruritus of cholestasis. Hepatology 1998 27 : 679 684.
5. McRae CA, Prince MI, Hudson M et al. Pain as a complication of use of opiate antagonists for symptom control in cholestasis. Gastroenterology 2003 125 : 591 596.